# OpenAI Unveils GPT-Rosalind, AI Model Designed for Life Sciences Research

OpenAI announced GPT-Rosalind, a specialized AI reasoning model built specifically for life sciences applications, marking the company's first major push into scientific research tools.

The new model targets four key areas: drug discovery, genomics analysis, protein reasoning, and scientific research workflows. Unlike general-purpose AI models, GPT-Rosalind is designed as a "frontier reasoning model," suggesting it has enhanced capabilities for complex scientific problem-solving in biological and medical contexts.

**What Changed**

This represents OpenAI's expansion beyond consumer and enterprise AI tools into specialized scientific domains. The model is named after Rosalind Franklin, the pioneering scientist whose work was crucial to discovering DNA's structure—a fitting tribute for a tool aimed at biological research.

**Why It Matters**

Drug discovery typically takes years and costs billions